</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
#6c6c7e #394d5d {{custommediaemailsadvanced::eyebrow_copy}} {{custommediaemailsadvanced::eyebrow_background_color}} {{custommediaemailsadvanced::eyebrow_text_color}} {{custommediaemailsadvanced::is_partner_podcast}} {{custommediaemailsadvanced::partner_podcast_buttons_lead_in_text}} {{custommediaemailsadvanced::partner_podcast_spotify_url}} {{custommediaemailsadvanced::partner_podcast_apple_url}} {{custommediaemailsadvanced::partner_podcast_google_url}} /uploads/anivive_s_i_n_e_artboard_96_2_x-db0f6f99aa61307d2d6c37badf9c55d2.jpg {{custommediaemailsadvanced::logo_self_hosted}} 72 {{custommediaemailsadvanced::logo_height}} {{custommediaemailsadvanced::logo_padding}} {{custommediaemailsadvanced::logo_alt_text}} {{custommediaemailsadvanced::logo_url}} {{custommediaemailsadvanced::no_border_under_logo}} {{custommediaemailsadvanced::apply_logo_over_background_image}} true /uploads/anivive_s_i_n_e_f_f_b_header_1_2_x-dbcb4f0414e1ec6d7afb7cadf7bab770.jpg {{custommediaemailsadvanced::desktop_header_image_alt}} {{custommediaemailsadvanced::desktop_header_image_alt_1x}} true true {{custommediaemailsadvanced::mobile_header_image}} {{custommediaemailsadvanced::mobile_header_image_alt}} {{custommediaemailsadvanced::add_left_right_padding_to_header_image}} {{custommediaemailsadvanced::add_bottom_padding_to_header_image}} {{custommediaemailsadvanced::add_top_padding_to_header_image}} {{custommediaemailsadvanced::header_image_padding_background_color}} {{custommediaemailsadvanced::scale_mobile_header_image}} {{custommediaemailsadvanced::background_height}} #000000 {{custommediaemailsadvanced::headline_image}} {{custommediaemailsadvanced::headline_image_self_hosted}} {{custommediaemailsadvanced::headline_url}} 480 379 {{custommediaemailsadvanced::headline_image_custom_css}} {{custommediaemailsadvanced::place_headline_image_above_header_image}} {{custommediaemailsadvanced::place_headline_image_below_header_image}} {{custommediaemailsadvanced::spacer_image}} {{custommediaemailsadvanced::spacer_image_self_hosted}} 600 {{custommediaemailsadvanced::spacer_image_height}} {{custommediaemailsadvanced::spacer_image_scale_desktop_padding_bottom}} {{custommediaemailsadvanced::spacer_image_scale_mobile_padding_bottom}} {{custommediaemailsadvanced::subhead_copy}} {{custommediaemailsadvanced::large_subhead_copy}} {{custommediaemailsadvanced::subhead_td_custom_css}} {{custommediaemailsadvanced::subhead_span_custom_css}} {{custommediaemailsadvanced::horizontal_rule_under_subhead}} {{custommediaemailsadvanced::intro_copy}} {{custommediaemailsadvanced::intro_centered}} {{custommediaemailsadvanced::intro_copy_td_custom_css}} {{custommediaemailsadvanced::intro_copy_span_custom_css}} {{custommediaemailsadvanced::horizontal_rule_under_intro}}

The best practices for diagnosing and treating canine lymphoma are moving forward at a rapid pace. In our recent webinar, you heard about a new treatment option that offers at{nbh}home administration and uses SINE technology to target cancer cells. There’s much more to learn about how SINE drugs specifically kill cancer cells while generally sparing healthy cells. Check out the SINE Technology Technical Bulletin to learn more about the mechanism of action and clinical applications for this novel class of{nbs}drugs. 

{{custommediaemailsadvanced::custom_body_text_color}} #f3f6f8 padding-top:30px; padding-left: 50px; padding-right: 50px; {{custommediaemailsadvanced::body_span_custom_css}} {{custommediaemailsadvanced::custom_body_horizontal_rule_color}} {{custommediaemailsadvanced::ordered_list_bullet_1}} 1 {{custommediaemailsadvanced::custom_icon_1}} {{custommediaemailsadvanced::custom_icon_1_self_hosted}} {{custommediaemailsadvanced::custom_icon_1_width}} {{custommediaemailsadvanced::ordered_list_bullet_2}} 2 {{custommediaemailsadvanced::custom_icon_2}} {{custommediaemailsadvanced::custom_icon_2_self_hosted}} {{custommediaemailsadvanced::custom_icon_2_width}} {{custommediaemailsadvanced::ordered_list_bullet_3}} 3 {{custommediaemailsadvanced::custom_icon_3}} {{custommediaemailsadvanced::custom_icon_3_self_hosted}} {{custommediaemailsadvanced::custom_icon_3_width}} {{custommediaemailsadvanced::ordered_list_bullet_4}} 4 {{custommediaemailsadvanced::custom_icon_4}} {{custommediaemailsadvanced::custom_icon_4_self_hosted}} {{custommediaemailsadvanced::custom_icon_4_width}} {{custommediaemailsadvanced::ordered_list_bullet_5}} 5 {{custommediaemailsadvanced::custom_icon_5}} {{custommediaemailsadvanced::custom_icon_5_self_hosted}} {{custommediaemailsadvanced::custom_icon_5_width}} #000000 {{custommediaemailsadvanced::center_icons_in_mobile}} {{custommediaemailsadvanced::ordered_list_bullet_td_custom_css}} {{custommediaemailsadvanced::ordered_list_bullet_span_custom_css}} {{custommediaemailsadvanced::body_2_copy}} {{custommediaemailsadvanced::body_2_td_custom_css}} {{custommediaemailsadvanced::body_2_span_custom_css}} {{custommediaemailsadvanced::closing_emphasis_copy}} {{custommediaemailsadvanced::closing_emphasis_link_text}} {{custommediaemailsadvanced::closing_emphasis_link_url}} {{custommediaemailsadvanced::closing_emphasis_link_color}} {{custommediaemailsadvanced::closing_emphasis_td_custom_css}} {{custommediaemailsadvanced::closing_emphasis_span_custom_css}} background-color: #394d5d; Read up on SINE technology to{br}help as many patients as{nbs}possible {{custommediaemailsadvanced::cta_line_1_custom_text_color}} true {{custommediaemailsadvanced::cta_line_2}} {{custommediaemailsadvanced::cta_line_2_custom_text_color}} {{custommediaemailsadvanced::cta_line_2_link}} Get the bulletin now #6c6c7e {{custommediaemailsadvanced::custom_button_text_color}} https://www.cliniciansbrief.com/sine-technology-novel-class-antineoplastic-drugs {{custommediaemailsadvanced::footnote}} {{custommediaemailsadvanced::large_footnote_copy}} {{custommediaemailsadvanced::footnote_td_custom_css}} {{custommediaemailsadvanced::footnote_span_custom_css}} {{custommediaemailsadvanced::pre_footer_copy}} {{custommediaemailsadvanced::pre_footer_center}}
New Technology Makes It Possible to Fight Cancer Without Chemotherapy
{{custommediaemailsadvanced::logo_alt_text}}
{{custommediaemailsadvanced::headline}}

The best practices for diagnosing and treating canine lymphoma are moving forward at a rapid pace. In our recent webinar, you heard about a new treatment option that offers at{nbh}home administration and uses SINE technology to target cancer cells. There’s much more to learn about how SINE drugs specifically kill cancer cells while generally sparing healthy cells. Check out the SINE Technology Technical Bulletin to learn more about the mechanism of action and clinical applications for this novel class of{nbs}drugs. 

Read up on SINE technology to{br}help as many patients as{nbs}possible
{{custommediaemailsadvanced::cta_line_2}}
Get the bulletin now
{{custommediaemailsadvanced::logo_alt_text}}
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
New Technology Makes It Possible to Fight Cancer Without Chemotherapy
{{custommediaemailsadvanced::logo_alt_text}}
{{custommediaemailsadvanced::headline}}

The best practices for diagnosing and treating canine lymphoma are moving forward at a rapid pace. In our recent webinar, you heard about a new treatment option that offers at{nbh}home administration and uses SINE technology to target cancer cells. There’s much more to learn about how SINE drugs specifically kill cancer cells while generally sparing healthy cells. Check out the SINE Technology Technical Bulletin to learn more about the mechanism of action and clinical applications for this novel class of{nbs}drugs. 

Read up on SINE technology to{br}help as many patients as{nbs}possible
{{custommediaemailsadvanced::cta_line_2}}
Get the bulletin now
{{custommediaemailsadvanced::logo_alt_text}}